Natco Pharma gets USFDA approval for Tipiracil Hydrochloride and Trifluridine Tablets

The US Food and Drug Administration (USFDA) granted final approval to the abbreviated new drug application (ANDA) for Tipiracil Hydrochloride and Trifluridine Tablets, the generic version of Lonsurf sold in the US by Taiho Oncology Inc, Natco said in a regulatory filing.

Natco Pharma gets USFDA approval for Tipiracil Hydrochloride and Trifluridine Tablets
"Natco believes it is one of the first-to-file for the product and may be eligible for a 180-day exclusivity at the time of launch," it added, image- Pixabay

Natco Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic Tipiracil Hydrochloride and Trifluridine tablets indicated primarily for the treatment of colorectal cancer.

The US Food and Drug Administration (USFDA) granted final approval to the abbreviated new drug application (ANDA) for Tipiracil Hydrochloride and Trifluridine Tablets, the generic version of Lonsurf sold in the US by Taiho Oncology Inc, Natco said in a regulatory filing.

"Natco believes it is one of the first-to-file for the product and may be eligible for a 180-day exclusivity at the time of launch," it added.

Lonsurf had generated annual sales of USD 211 million in the US during the 12-month period ended December 2022, the company said citing IQVIA data.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.

 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-epfo-retirement-pension-scheme-early-pension-superannuation-disablement-widow-child-orphan-pension-online-login-passbook-employee-provident-fund-327598

EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know

https://www.zeebiz.com/trending/news-rains-in-tamil-nadu-orange-alert-issues-for-november-26-regional-meteorological-centre-cyclone-south-andaman-sea-puducherry-karaikkal-327505

Tamil Nadu Weather News: Heavy rain likely in TN, orange alert issued for Nov 26

https://www.zeebiz.com/markets/stocks/photo-gallery-psu-and-largecap-shares-to-buy-short-term-bse-sensex-nse-nifty-pick-of-the-day-327460

Stocks to buy: Hindustan Aeronautics, Zomato, Tata Tech, GMR Airports among analysts' top picks

https://www.zeebiz.com/trending/photo-gallery-delhi-aqi-today-air-pollution-level-falls-to-very-poor-quality-schools-closed-work-from-home-started-in-office-government-bans-firecrackers-sale-on-ecommerce-sites-city-records-lowest-temperature-327481

Delhi AQI Today: Air quality index level drops; city records season's lowest temperature

https://www.zeebiz.com/market-news/news-tata-motors-muthoot-finance-crisil-stocks-to-buy-axis-direct-bse-nse-327646

Tata Motors, Muthoot Finance and 3 more: Axis Direct recommends buying these stocks for 2 weeks; check targets, stop losses

https://www.zeebiz.com/personal-finance/photo-gallery-top-5-small-cap-mutual-funds-with-best-sip-xirr-returns-in-1-year-calculator-inr-rs-25000-monthly-investment-has-grown-to-355000-nifty-150-tri-bse-invesco-edelweiss-hsbc-franklin-nav-aum-327419

Top 5 Small Cap Mutual Funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-sbi-sip-mutual-funds-with-highest-sip-return-xirr-in-1-year-capital-gains-calculator-how-inr-rs-25000-monthly-investment-has-grown-to-bse-sp-nifty-multi-large-health-tech-banking-326674

Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404

Written By: PTI
Updated: Fri, Jun 16, 2023
05:40 PM IST
Mumbai, PTI
RELATED NEWS
Natco Pharma acquires 40 million shares in eGenesis Inc Natco Pharma acquires 40 million shares in eGenesis Inc
Natco Pharma submits abbreviated new drug application with USFDA for generic cancer drug Natco Pharma submits abbreviated new drug application with USFDA for generic cancer drug
Natco Pharma rises nearly 2% after mid-cap firm submits application for Rimegepant Sulfate tablets to US FDA Natco Pharma rises nearly 2% after mid-cap firm submits application for Rimegepant Sulfate tablets to US FDA

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x